Executive Summary
The 30 filings reveal a significant wave of leadership transitions across US-listed companies, with a notable concentration of CFO changes (8 out of 30 filings) and strategic board refreshments.
While most transitions are orderly and neutral, several carry strong investment signals: Vaxcyte's appointment of two senior Pfizer/Eli Lilly executives ahead of a pivotal Phase 3 data readout and T-Mobile's hiring of a former Shell CFO to succeed its retiring CFO are distinctly bullish. Conversely, Netcapital's board shake-up amid an SEC lawsuit and Guidewire's mixed results with declining license revenue and heavy buyback activity represent key risks. A clear sector theme is the 'CFO Carousel', with 8 companies announcing CFO departures or appointments, often tied to strategic pivots (e.g., Resources Connection appointing its Chief AI Officer as interim CFO). Period-over-period data from Guidewire and UiPath shows strong top-line growth (23% and 13% YoY, respectively) but mixed profitability signals, with Guidewire's Q4 GAAP net income falling 40% due to a foreign currency loss. The aggregate picture is one of proactive governance and strategic repositioning, creating both opportunities and risks for investors.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from September 02, 2026.
Investment Signals (10)
- Vaxcyte ↓ (BULLISH)▲
Appointed two top-tier executives (Pfizer's CMO for Prevnar 13/20, Eli Lilly's GC) ahead of VAX-31 Phase 3 data in October 2026, signaling strong preparation for BLA submission and commercialization
- T-Mobile US ↓ (BULLISH)▲
Hired Jessica Uhl (ex-Shell CFO, GE Vernova President) as CFO Designate, a clear upgrade in financial leadership depth, while reaffirming 2026 guidance and capital return program
-
FY2026 total revenue grew 23% YoY to $1.475B and ARR grew 19% to $1.242B, but license revenue declined 7% and Q4 GAAP net income fell 40% due to a $24M FX loss, creating a mixed signal [BULLISH/BEARISH]
- ▲
Q2 FY2027 revenue grew 13% YoY to $410M and ARR grew 12% to $1.938B, but net new ARR was only $37M and dollar-based net retention slowed to 109%, indicating decelerating expansion [BULLISH/BEARISH]
- MediaAlpha ↓ (BULLISH)▲
Raised Q3 2026 guidance to at or above the top end of prior ranges, concurrent with a CFO transition to a former CFO, signaling strong near-term operational momentum
- Byrna Technologies ↓ (BULLISH)▲
Appointed a former long-time Axon board member (Matthew McBrady) to its board, bringing deep experience from Axon's >$50B growth journey, a strong signal for Byrna's next growth phase
- Albemarle ↓ (BULLISH)▲
Announced a clear CEO succession plan with Ragnar Udd (ex-BHP Chief Commercial Officer) taking over in Feb 2027, ensuring leadership continuity in a critical lithium market cycle
- Bally's Corp ↓ (BEARISH)▲
CFO resignation for personal reasons with interim CFO appointment (former CEO), but the company has commenced a search, creating near-term uncertainty in financial leadership
- Netcapital ↓ (BEARISH)▲
Director resigned citing an SEC civil action filed against the company, with a new independent director appointed, signaling significant governance and regulatory risk
- Radiant Logistics ↓ (BULLISH)▲
Appointed a new COO who previously improved DB Schenker's North America operating margin by over 200% in five years, a strong signal for operational improvement
Risk Flags (10)
- Netcapital/SEC Lawsuit↓ [HIGH RISK]▼
Director Avi Liss resigned citing an SEC civil action filed on Aug 10, 2026, creating significant regulatory and governance overhang
- Guidewire Software/License Revenue Decline↓ [MEDIUM RISK]▼
License revenue declined 7% for FY2026 and 18% in Q4, indicating a potential shift in customer preference toward subscription models, which could pressure near-term margins
- UiPath/Slowing Expansion↓ [MEDIUM RISK]▼
Net new ARR of only $37M in Q2 FY2027 and dollar-based net retention of 109% (down from prior quarters) suggest decelerating customer expansion and potential market saturation
- Resources Connection/CFO Departure↓ [MEDIUM RISK]▼
CFO resignation effective Oct 2, 2026, with an interim CFO appointed who joined only in March 2026 as Chief AI Officer, creating a leadership gap during a strategic AI pivot
- Bally's Corp/CFO Vacancy↓ [MEDIUM RISK]▼
CFO resignation for personal reasons with no permanent successor named, creating uncertainty in financial oversight for a company with 20 casinos and significant leverage
- Frontdoor/CAO Departure↓ [LOW RISK]▼
VP, Chief Accounting Officer resigned effective Sep 18, 2026, with CFO assuming interim duties, creating a temporary gap in financial reporting leadership
- SCOTTS MIRACLE-GRO/CSO Departure↓ [LOW RISK]▼
EVP & Chief Strategy Officer departing Sep 30, 2026, with no successor named, potentially disrupting strategic planning amid a challenging consumer environment
- CF Industries/CAO Retirement↓ [LOW RISK]▼
VP, Corporate Controller and CAO retiring Mar 3, 2027, a routine departure but creates a transition risk in financial reporting
- James River Group/Director Departure↓ [LOW RISK]▼
Director not seeking re-election, a routine change but adds to board turnover in a challenging insurance market
-
Director resigned effective immediately with no reason or successor named, suggesting potential internal disagreement
Opportunities (10)
- Vaxcyte/VAX-31 Phase 3 Data↓ (OPPORTUNITY)◆
Topline data from the VAX-31 adult Phase 3 OPUS-1 trial narrowed to end of October 2026, with 6,191 adults dosed. Positive data could trigger a significant re-rating for this clinical-stage vaccine company
- T-Mobile US/CFO Upgrade↓ (OPPORTUNITY)◆
Jessica Uhl's appointment as CFO Designate brings deep energy and industrial finance experience, potentially driving more disciplined capital allocation and M&A strategy
- MediaAlpha/Guidance Raise↓ (OPPORTUNITY)◆
Q3 2026 guidance raised to at or above the top end, signaling strong ad spend recovery and operational leverage. The CFO transition to a former CFO ensures continuity
- Byrna Technologies/Board Expertise↓ (OPPORTUNITY)◆
Appointment of Matthew McBrady, a former Axon board member, provides deep expertise in scaling a public safety technology company, potentially accelerating Byrna's growth trajectory
- Albemarle/CEO Succession↓ (OPPORTUNITY)◆
Ragnar Udd's appointment as CEO brings extensive experience in commodities and global supply chains, well-suited to navigate the volatile lithium market
- Radiant Logistics/COO Appointment↓ (OPPORTUNITY)◆
New COO David Buss's track record of improving operating margins by over 200% at DB Schenker suggests significant operational improvement potential for Radiant
- WD-40/CFO Succession↓ (OPPORTUNITY)◆
Planned CFO transition with internal promotion of Division President, Americas, ensuring continuity while bringing fresh financial leadership from Galderma
- Bunge Global/CAO Succession↓ (OPPORTUNITY)◆
Orderly CAO transition with an internal promotion, ensuring continuity in financial controls and reporting
- Profound Medical/CEO Appointment↓ (OPPORTUNITY)◆
New President Richard Fabian brings 29 years of healthcare experience, including as CEO of FUJIFILM Sonosite, potentially accelerating commercialization of TULSA-PRO
- LB Pharmaceuticals/CFO Appointment↓ (OPPORTUNITY)◆
New CFO Joseph Miller led Aurinia through the commercial launch of LUPKYNIS, valuable experience as LB approaches pivotal NOVA-2 trial results for LB-102 in schizophrenia
Sector Themes (6)
- CFO Carousel◆
8 of 30 filings (27%) involved CFO changes, including departures (Resources Connection, Bally's, MediaAlpha), appointments (CarGurus, WD-40, LB Pharmaceuticals), and retirements (T-Mobile). This high turnover rate suggests companies are actively reshaping financial leadership to align with strategic pivots or respond to performance pressures.
- Board Refreshment for Growth◆
Multiple companies (Byrna, BNB Plus, Netcapital) are refreshing boards with directors bringing specific expertise (Axon growth, blockchain/AI, independent oversight), signaling a focus on governance modernization and strategic realignment.
- Pivotal Data Catalysts◆
Two clinical-stage companies (Vaxcyte, LB Pharmaceuticals) are approaching key data readouts (VAX-31 Phase 3, LB-102 NOVA-2), with leadership appointments timed to prepare for potential commercialization, creating binary event risk/reward.
- Orderly vs. Disorderly Succession◆
The majority of leadership changes are orderly (T-Mobile, Albemarle, WD-40, Bunge), but a few are disorderly (Netcapital/SEC, Bally's/personal reasons, Resources Connection/abrupt), creating a clear differentiation in execution risk.
- AI Integration in Leadership◆
Resources Connection's appointment of its Chief AI Officer as interim CFO and Ralph Lauren's expansion of the COO role to include AI strategy highlight a growing trend of embedding AI expertise into top management.
- Capital Allocation Divergence◆
Guidewire's $606.3M in share repurchases (despite declining license revenue) contrasts with T-Mobile's reaffirmed capital return program, showing divergent capital allocation strategies between growth and value companies.
Watch List (10)
-
Topline data expected end of October 2026. Positive results could drive significant upside; negative results would be a major setback.
-
Guidance raised to top end, watch for actual results and Q4 outlook in late October/early November 2026.
-
Monitor developments in the SEC civil action (Case No. 1:26-cv-13665) and any further board or management changes.
-
Watch for announcement of a permanent CFO, which could signal stability or further disruption.
-
Monitor for appointment of a permanent CFO and any updates on the AI strategy pivot.
-
Ragnar Udd becomes CEO on Feb 1, 2027. Watch for any strategic shifts in lithium operations or capital allocation.
-
Jessica Uhl becomes CFO in February 2027. Monitor for any changes to capital return or M&A strategy.
-
Pivotal Phase 3 data for LB-102 in schizophrenia. Positive results could lead to a significant re-rating.
-
Scheduled for November 16, 2026. Watch for any strategic updates or board changes.
-
Keith Stauffer becomes CFO on Nov 2, 2026. Monitor for any changes to financial strategy or guidance.
Filing Analyses
(30)
03-09-2026
Profound Medical Corp. appointed Richard Fabian as President, effective immediately, succeeding Mathieu Burtnyk who becomes Chief Technology Officer. Fabian brings over 29 years of healthcare industry experience, most recently as CEO of FUJIFILM Sonosite, and previously in senior roles at Philips Healthcare. The leadership change aims to sharpen execution while retaining Burtnyk to lead clinical innovation.
- · Richard Fabian holds a Bachelor of Economics from the University of Michigan and an MBA from the University of Pittsburgh Joseph M. Katz Graduate School of Business.
- · Mathieu Burtnyk is the inventor of the patented closed-loop temperature feedback control algorithm used by TULSA-PRO®.
- · Profound Medical's technologies are approved across major global markets including FDA clearance for TULSA-PRO in the US and Sonalleve HDE for osteoid osteomas.
03-09-2026
Byrna Technologies appointed Matthew McBrady, Ph.D., a former long-time board member of Axon Enterprise (market cap >$50B), to its Board of Directors, increasing board size from seven to eight as part of a planned refreshment strategy. Dr. McBrady brings deep experience from Axon's growth journey, capital markets expertise as a former hedge fund and private equity investor, and currently serves as CFO of GoBrands (GoPuff). The appointment is expected to provide valuable insights for Byrna's next growth phase, though no specific financial metrics or performance data were disclosed in this filing.
- · Dr. McBrady served on Axon's board from 2001 to 2014 and again from 2016 to 2026, chairing Audit, Compensation, and M&A & Capital Structure Committees.
- · He currently serves as CFO of GoBrands (GoPuff) since 2025 and previously spent five years as Professor of Practice in Finance at Darden School.
- · Earlier career includes roles as Managing Director and CIO of Multi-Strategy Hedge Funds at BlackRock, and Senior Associate at Bain Capital.
- · He served as an international economist for President Clinton's Council of Economic Advisers and the U.S. Treasury from 1998 to 2000.
- · Dr. McBrady holds a B.A. in Economics from Harvard, an M.Sc. from Oxford (Marshall Scholar), and a Ph.D. in Business Economics from Harvard.
03-09-2026
The Scotts Miracle-Gro Company announced the departure of Christopher J. Hagedorn, Executive Vice President & Chief Strategy Officer, effective September 30, 2026. The separation was mutually agreed upon on August 29, 2026. No financial details or replacement plans were disclosed.
- · Departure effective date: September 30, 2026
- · Agreement date: August 29, 2026
- · No successor or interim arrangement mentioned
03-09-2026
Guidewire Software reported strong fiscal year 2026 results with total revenue up 23% to $1,475.4M and ARR growing 19% to $1,242M. However, license revenue declined 7% for the full year and 18% in Q4, while GAAP net income in Q4 fell to $31.4M from $52.0M a year ago due to a $24.0M foreign currency loss. The company provided fiscal 2027 guidance for ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.
- · GAAP diluted net income per share for FY 2026 was $1.63, up from $0.81 in FY 2025.
- · Non-GAAP diluted net income per share for FY 2026 was $3.43, up from $2.51 in FY 2025.
- · Cash, cash equivalents, and investments decreased to $1,215.3M from $1,483.2M at year-end FY 2025, partly due to $606.3M in share repurchases.
- · The company repurchased 4,085,350 shares at an average price of $148.41 during FY 2026.
- · GAAP net income in Q4 FY 2026 was negatively impacted by a $24.0M foreign currency loss, compared to a $2.8M gain in Q4 FY 2025.
- · Fiscal year 2027 guidance includes ending ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.
- · The company has over 570 insurers in 44 countries and has completed 1700+ implementation projects.
03-09-2026
CF Industries Holdings, Inc. disclosed that Vice President, Corporate Controller, and Chief Accounting Officer Richard A. Hoker intends to retire effective March 3, 2027. The filing provides no financial data or performance metrics, only a routine officer departure announcement.
03-09-2026
NETSTREIT Corp. announced the mutual departure of Sofia Chernylo as Senior Vice President and Chief Accounting Officer, effective September 1, 2026, with no disagreement over accounting matters. Matthew Fennewald, age 36, was appointed as her successor, bringing internal experience as Vice President, Corporate Controller since February 2024 and prior roles at PricewaterhouseCoopers and Crowe Horwath. The transition appears orderly and routine, with no new material plans or arrangements disclosed.
- · Matthew Fennewald joined NETSTREIT in August 2020 and has served as Vice President, Corporate Controller since February 2024.
- · Prior roles at NETSTREIT include Director, Corporate Controller (March 2023–February 2024), Corporate Controller (March 2022–February 2023), and Financial Reporting Manager (August 2020–February 2022).
- · Before NETSTREIT, Fennewald worked at PricewaterhouseCoopers LLP (2015–2020) and Crowe Horwath LLP (2012–2015).
- · Fennewald holds a Master of Science in Auditing and Financial Accounting from the University of North Texas and is a licensed CPA.
- · No family relationships or reportable transactions exist between Fennewald and the company's directors or executive officers.
03-09-2026
Resources Connection, Inc. (RGP) announced the resignation of CFO Jennifer Y. Ryu, effective October 2, 2026, and the appointment of Jessica Block as interim CFO. Ms. Block, who joined RGP in March 2026 as Chief AI Officer, brings over 20 years of experience in professional services, including a prior interim CFO role at Factor. The company will initiate a search for a permanent successor, while Ms. Block's appointment aims to ensure continuity and continued focus on strategic priorities, including advancing RGP's AI strategy.
- · RGP has served 90% of the Fortune 100 as of May 2026.
- · RGP has been recognized by U.S. News & World Report (2025-2026 Best Companies to Work for) and Forbes (America’s Best Midsize Employers 2026, America’s Best Management Consulting Firms 2025, World’s Best Management Consulting Firms 2025).
- · RGP is listed on the Nasdaq Global Select Market, the exchange’s highest tier by listing standards.
03-09-2026
On September 3, 2026, James River Group Holdings, Inc. (JRVR) disclosed in an 8-K filing that director Thomas L. Brown will not seek re-election at the 2026 annual general meeting, effective August 31, 2026. The departure is not due to any disagreement with the company's operations, policies, or practices. The filing does not include any financial data or forward-looking guidance.
- · Mr. Brown's decision was not due to any disagreement with the company.
- · The departure relates to the 2026 annual general meeting of shareholders.
03-09-2026
Bunge Global SA announced the planned retirement of Controller and CAO Matt Simmons effective March 31, 2027, with Richard James succeeding him on April 1, 2027. The transition is orderly and not due to any disagreement. Mr. James brings over 14 years of experience at Bunge and multiple professional certifications.
- · Matt Simmons will retire as Controller and CAO effective March 31, 2027, and will remain through the transition period.
- · Richard James, age 45, has served as Vice President, Finance Integration and Transformation since December 2022.
- · Richard James holds a Bachelor of Science in Biology from the University of London (2002) and an MBA from Columbia Business School (2012).
- · Richard James is a CPA, Chartered Professional Accountant (Canada), Chartered Accountant (England & Wales), and Certified Internal Auditor.
03-09-2026
Vaxcyte appointed Luis Jodar, Ph.D. as Chief Medical Officer and David McAvoy, J.D. as Chief Legal Officer, strengthening its leadership ahead of a key clinical milestone. The company also narrowed its guidance for topline data from the VAX-31 adult Phase 3 OPUS-1 trial to end of October 2026, from the prior Q4 2026 range. The appointments and data timeline signal progress toward a planned BLA submission and potential commercialization, though the company remains a clinical-stage entity with no approved products.
- · Luis Jodar spent 17 years at Pfizer, most recently as SVP and CMO for Vaccines and Infectious Diseases, and led clinical/regulatory work for Prevnar 13 and Prevnar 20.
- · David McAvoy spent 27 years at Eli Lilly in senior legal roles and was General Counsel of Endocyte through its $2.1B acquisition by Novartis.
- · The OPUS program includes three fully enrolled trials with 6,191 adults dosed total; ~3,500 received VAX-31.
- · OPUS-2 and OPUS-3 topline data expected in first half of 2027.
- · VAX-31 is the broadest-spectrum PCV candidate in the clinic today (31-valent).
- · VAX-24 has positive Phase 2 results in adults and infants.
- · VAX-A1 (Group A Strep) is in Phase 1.
- · VAX-GI (Shigella) is in pipeline.
- · XpressCF platform is exclusively licensed from Sutro Biopharma.
03-09-2026
Ralph Lauren Corporation announced expanded roles for key enterprise leaders effective November 29, 2026, following the retirement of COO Bob Ranftl. Halide Alagöz becomes Chief Operating & Product Officer, adding AI strategy and architecture & design to her product and merchandising responsibilities; CFO Justin Picicci adds real estate and logistics; CMO Iris Langlois-Meurinne adds licensing; and Katie Ioanilli adds the Design with Intent initiative. The changes support the Next Great Chapter: Drive strategy, but no financial metrics or performance data were disclosed.
- · Halide Alagöz will assume leadership of AI strategy and architecture & design organization.
- · Justin Picicci will add global responsibility for real estate and logistics.
- · Iris Langlois-Meurinne will take on leadership of Ralph Lauren’s licensing business.
- · Katie Ioanilli will expand her role to include Design with Intent, an industry-leading cultural collaboration initiative.
- · Bob Ranftl's retirement is effective November 29, 2026.
03-09-2026
T-Mobile US announced the planned retirement of CFO Peter Osvaldik in July 2027 and the appointment of Jessica Uhl as CFO Designate, effective mid-September 2026, to succeed him in February 2027. Uhl brings extensive financial leadership from Shell and GE Vernova. The company reaffirmed its 2026 financial guidance and capital return program.
- · Peter Osvaldik joined T-Mobile in 2016 and has served as CFO since 2020.
- · Osvaldik's one-year contract extension was previously made to support the CEO transition.
- · Jessica Uhl has a 30-year career, was CFO of Shell, and most recently President of GE Vernova.
- · The transition includes an extended transition period and a Strategic Advisor role for Osvaldik until his planned retirement on July 1, 2027.
03-09-2026
BNB Plus Corp. announced the resignation of three directors (Robert B. Catell, Joseph D. Ceccoli, Dr. Yacov Shamash) effective September 3, 2026, with no disagreement cited, and appointed three new directors (Richard Shorten, Todd Larsen, Lok Lee) to fill the vacancies. The new directors bring ties to blockchain/AI infrastructure and a strategic advisory engagement with GlobalStake, which is affiliated with a major shareholder (Comstock). The company has paid a $300,000 pre-paid advisory fee for a four-month strategic review, and recent private placements with Comstock GP generated gross proceeds of $5.0 million and $747.8 thousand.
- · New directors Larsen and Lee will serve on Audit and Compensation Committees; Larsen also on Nominating Committee.
- · Compensation for new directors to be agreed upon at a later date.
- · GlobalStake strategic review will cover business, assets, and capital structure over an initial four-month term.
- · Comstock GP is a current shareholder and participant in both the October 2025 PIPE and May 2026 private placement.
- · No disagreements were cited for the resignations.
03-09-2026
Frontdoor, Inc. announced the resignation of Sally J. Shanks, Vice President, Chief Accounting Officer and Controller, effective September 18, 2026, to pursue other business opportunities. Her departure is not due to any disagreement with the company. CFO Jason L. Bailey will assume principal accounting officer duties until a successor is appointed.
- · Resignation effective date: September 18, 2026
- · No disagreement with company, management, or board cited
- · CFO Jason L. Bailey will serve as interim principal accounting officer
03-09-2026
ESS Tech, Inc. entered into employment agreements with CFO Kate Suhadolnik and CSO/GC Kelly F. Goodman on August 28, 2026, formalizing terms without any change in roles or responsibilities. Each executive receives a base salary of $380,000 and enhanced severance benefits tied to a change-in-control protective period, including 12 months' salary, COBRA premiums, and full equity acceleration. The agreements also include customary non-compete and non-solicitation covenants.
- · Employment agreements were not entered into in connection with any change in title, role, or responsibilities.
- · Annual cash incentive bonus eligibility terms remain unchanged from prior disclosures.
- · Severance benefits apply only during the CIC Protective Period (one month before to 12 months after a Change in Control).
- · Severance includes 12 months' base salary, 12 months of COBRA premiums, and full acceleration of unvested equity awards.
- · Agreements contain customary confidentiality, non-solicitation, and non-competition covenants.
03-09-2026
UiPath reported Q2 FY2027 revenue of $410 million, up 13% YoY, and ARR of $1.938 billion, up 12% YoY, with GAAP operating income of $32 million and non-GAAP operating income of $89 million. The company announced leadership changes, including a new CFO and a new Board member, and provided Q3 and full-year guidance. However, net new ARR of $37 million was modest, and the dollar-based net retention rate of 109% indicates slowing expansion.
- · Net new ARR of $37 million in Q2 FY2027.
- · Dollar-based net retention rate of 109%.
- · GAAP gross margin of 80% and non-GAAP gross margin of 82%.
- · Leadership changes: Ashim Gupta to focus solely on COO role; Hitesh Ramani promoted to CFO; Brad Brubaker named Chief Legal & Administrative Officer.
- · Yazdi Bagli appointed to the Board of Directors.
- · Q3 FY2027 guidance: revenue $440M-$445M, ARR $1.992B-$1.997B, non-GAAP operating income ~$100M.
- · Full year FY2027 guidance: revenue $1.789B-$1.794B, ARR $2.065B-$2.070B, non-GAAP operating income ~$445M.
- · Cash position of $1.405 billion as of July 31, 2026.
03-09-2026
Bally's Corporation announced the resignation of EVP and CFO Mira Mircheva for personal reasons, effective September 4, 2026, with a transition period through September 30, 2026. The Board appointed President and Board member George Papanier as Interim CFO, effective September 4, 2026, leveraging his 40+ years of gaming industry experience and prior CFO role in 2023. The company has commenced a search for a permanent CFO, and management expressed confidence in continued operational and financial stability.
- · Mira Mircheva's resignation is effective September 4, 2026, with a transition period through September 30, 2026.
- · George Papanier previously served as interim CFO in 2023 and as CEO from February 2011 to October 2021.
- · Bally's operates 20 casinos across 11 U.S. states and one in Newcastle, UK, with approximately 17,700 slot machines, 630 table games, and 3,950 hotel rooms.
- · Bally's has over 12,000 employees globally and holds a majority interest in Bally's Intralot S.A.
03-09-2026
GrabAGun Digital Holdings Inc. (PEW-WT) announced the departure of CFO Justin Hilty, effective September 1, 2026, under a Separation Agreement. The agreement includes a six-month advisory period (minimum 40 hours/month) with an hourly cash fee, acceleration of 66,667 unvested RSUs, and standard restrictive covenants. No financial terms of the consulting fee or any severance payment were disclosed.
- · Mr. Hilty resigned as CFO effective August 14, 2026, and retired effective September 1, 2026.
- · Advisory period runs from September 1, 2026 through March 1, 2027.
- · Mr. Hilty remains subject to restrictive covenants from a Non-Competition and Non-Solicitation Agreement dated January 6, 2025.
- · The Separation Agreement includes a general release of claims through the Separation Date.
03-09-2026
LiveWire Group, Inc. announced the resignation of Paul Krause from its Board of Directors effective August 31, 2026, and the appointment of Matt Ryan to the Board effective September 1, 2026. Mr. Ryan, who serves as Chief Marketing and Technology Officer of Harley-Davidson, Inc., will not receive additional compensation for his director role.
- · Paul Krause resigned effective end of day August 31, 2026.
- · Matt Ryan was appointed effective September 1, 2026.
- · Mr. Ryan will not receive additional compensation for his board service due to his current role at Harley-Davidson, Inc.
03-09-2026
Netcapital Inc. (NCPLW) disclosed the resignation of director Avi Liss on August 27, 2026, citing the SEC civil action filed against the company and certain individuals. The board elected Cesar Herrera as a new independent director on August 30, 2026, filling the vacancy and appointing him to the Audit and Compensation Committees. The filing reflects a board shake-up amid an SEC lawsuit, but no financial metrics or performance data are provided.
- · The SEC civil action was filed on August 10, 2026, in the U.S. District Court for the District of Massachusetts (Case No. 1:26-cv-13665).
- · Mr. Liss stated he did not know of, be involved in, participate in, or receive any financial benefit from the alleged conduct.
- · Cesar Herrera has served as CEO and director of KRTL Holding Group Inc. since December 2021 and holds a California real estate broker license since 2006.
- · The board determined all three directors are independent under Nasdaq rules.
- · Mr. Herrera was not designated as an audit committee financial expert.
03-09-2026
Albemarle Corporation announced a CEO succession plan: Ragnar Udd will become President and CEO effective February 1, 2027, succeeding Kent Masters, who will transition to Executive Chairman. Udd brings over 25 years of experience from BHP, where he served as Chief Commercial Officer. The transition is designed to ensure leadership continuity, with Masters serving as Executive Chairman through the 2027 annual meeting.
- · Udd will join the Albemarle Board of Directors upon becoming CEO.
- · Masters will serve as Executive Chairman through the 2027 annual meeting, after which his role will be reviewed as part of the Board's annual director nomination process.
- · Udd's experience includes roles as President Americas at BHP (leading copper and potash businesses), interim Chief Technology Officer, BHP Mitsubishi Asset President, and Vice President Logistics and Infrastructure for Western Australia Iron Ore.
03-09-2026
Radiant Logistics appointed David Buss as Senior Vice President and COO, effective August 31, 2026. Mr. Buss brings over 30 years of logistics experience, including a prior role as CEO of DB Schenker's North America Cluster where he improved operating margin by over 200% in five years. The company also announced its 2026 Annual Meeting will be held on November 16, 2026, with record and proposal deadlines in September.
- · Mr. Buss served as an independent private equity transportation logistics advisor from August 2025 to July 2026.
- · He was promoted to the North America Cluster leadership role at DB Schenker in April 2023 and served on the integration steering committee for the USA Truck acquisition until July 2025.
- · The employment agreement provides six months severance for termination due to death/disability or without cause, and twelve months severance if termination occurs within nine months after a Change of Control.
- · Stockholder proposals for the 2026 Annual Meeting must be received by September 27, 2026; director nominations by September 17, 2026.
- · The record date for voting at the Annual Meeting is September 29, 2026.
03-09-2026
LB Pharmaceuticals appointed Joseph Miller as CFO, effective September 3, 2026. Miller brings over 20 years of biopharmaceutical finance experience, including leading Aurinia Pharmaceuticals through its commercial launch of LUPKYNIS. The company is approaching pivotal NOVA-2 clinical trial results for lead candidate LB-102 in schizophrenia, but remains pre-revenue with no approved products and faces significant development and regulatory risks.
- · Joseph Miller previously served as CFO of Aurinia Pharmaceuticals, where he oversaw the commercial launch of LUPKYNIS, the first FDA-approved oral therapy for active lupus nephritis.
- · Miller also served as CFO, Principal Executive Officer, and Corporate Secretary of Avalo Therapeutics, leading acquisitions of Aevi Genomic Medicine and Ichorion Therapeutics and the divestiture of Avalo's commercial portfolio to Aytu BioScience.
- · Earlier roles include VP of Finance at Sucampo Pharmaceuticals (which merged with Mallinckrodt) and finance leadership at QIAGEN, Eppendorf, and KPMG LLP.
- · Miller holds a B.S. in accounting from Villanova University and is a Certified Public Accountant.
- · The company has no approved products and is pre-revenue, with all forward-looking statements subject to risks including limited operating history, historical losses, and dependence on LB-102.
03-09-2026
Alaska Silver Corp. granted 375,000 stock options to non-executive directors at C$0.71 per share for a five-year term, as part of its director compensation policy. The company also provided an update on its Illinois Creek Project in Alaska, which hosts significant silver, gold, zinc, and lead resources. No financial results or period-over-period comparisons were included in this filing.
- · The Illinois Creek Project is located 38 km from the Yukon River, the region's primary marine transportation corridor.
- · The Waterpump Creek zone remains open to the north and south.
- · The Illinois Creek Mine was a past producer that closed in 1998 and was reclaimed in 2002 due to low metal prices.
- · The company is headquartered in Alaska and Arizona.
03-09-2026
CarGurus appointed Matthew Mandel as CFO, effective Oct. 19, 2026, succeeding CEO Jason Trevisan who served as interim CFO since March 2025. Mandel brings experience from Fleetio, Cometeer, Wayfair, and private equity firms. The filing contains no financial results or period-over-period comparisons.
- · Mandel's start date is Oct. 19, 2026.
- · He will report to CEO Jason Trevisan.
- · Mandel holds an MBA from Harvard Business School and a BA from Duke University.
- · He was CFO and COO at Fleetio since November 2023.
- · Trevisan had served as interim principal financial and principal accounting officer since March 2025.
03-09-2026
MediaAlpha announced that Pat Thompson will step down as CFO effective October 1, 2026, with Tigran Sinanyan (SVP of Finance and former CFO from 2015-2021) succeeding him. The company also raised its Q3 2026 guidance, now expecting Revenue, Contribution, and Adjusted EBITDA at or above the top end of previously disclosed ranges. The transition is orderly, with Thompson remaining as consultant through February 2027, and the guidance upgrade signals strong near-term performance.
- · Pat Thompson's last day as CFO is October 1, 2026; his last day with the company is October 30, 2026, followed by a consulting role through February 2027.
- · Tigran Sinanyan previously served as MediaAlpha's CFO from 2015 to 2021 and as VP of Finance from 2012 to 2015, and rejoined as SVP of Finance in July 2025.
- · The company generated over 141 million Consumer Referrals in 2025 and powered $2.2 billion in programmatic advertising spend.
- · MediaAlpha has more than 1,150 active partners.
03-09-2026
Cyabra, Inc. (formerly Trailblazer Holdings, Inc.) held a Special Meeting of Stockholders on September 2, 2026, where shareholders approved two proposals: the issuance of shares in connection with a Private Placement, Exchange Agreement, and Conversion Agreements (exceeding 20% of outstanding common stock), and an amendment to the 2026 Omnibus Equity Incentive Plan increasing the share reserve by 20,000,000 shares. The Plan Amendment also introduces an annual increase in the share reserve to 15% of fully diluted capitalization. Both proposals passed with strong majority support, though the Plan Amendment saw a notable minority of votes against it.
- · The Plan Amendment was previously approved by the Board of Directors on July 31, 2026, subject to stockholder approval.
- · The Company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.
- · The Company's common stock trades on The Nasdaq Stock Market LLC under the symbol CYAB.
- · The Company's principal executive office is located at 13 Gershon Shatz, Tel Aviv, Israel.
03-09-2026
Federal Home Loan Bank of Des Moines announced the appointment of Wil W. Osborn as President and CEO, effective October 1, 2026, succeeding Kristina K. Williams who is retiring after serving since January 2020. Osborn, currently the Bank's Chief Business Officer and a former CFO of FHLB Topeka, was selected through a comprehensive succession planning process led by the board. The transition represents a leadership change at a key government-sponsored enterprise with over 1,200 member institutions.
- · Transition effective date: October 1, 2026
- · Williams announced retirement in January 2026
- · Board engaged an executive search firm for the process
- · Osborn served as CFO of Federal Home Loan Bank of Topeka from 2010 before joining FHLB Des Moines in 2020
- · FHLB Des Moines serves 13 states and 3 U.S. Pacific territories
- · Bank is wholly owned by its members and receives no taxpayer funding
03-09-2026
On September 1, 2026, Paul H. Brown notified Old Dominion Electric Cooperative of his resignation from the board of directors, effective immediately. The filing does not provide a reason for the departure or name a successor. No financial impact or other operational changes were disclosed.
- · Resignation effective September 1, 2026, the same day as the notification.
- · No successor or interim replacement has been announced.
- · The filing does not disclose any disagreement between Mr. Brown and the company.
03-09-2026
WD-40 Company announced the hiring of Keith Stauffer as Vice President, Global Finance, effective September 7, 2026, who will become Chief Financial Officer on November 2, 2026. Current CFO Sara Hyzer will transition to Division President, Americas on that same date, continuing in the CFO role through the filing of the fiscal year 2026 10-K. The leadership change follows a planned succession and aims to ensure a smooth handoff.
- · Prior to WD-40, Mr. Stauffer served as CFO, U.S. at Galderma S.A. and as CFO of TerrAscend Corp. from 2020 to 2025.
- · He holds a Bachelor of Science in Industrial Engineering and an MBA from Purdue University.
- · Ms. Hyzer will remain CFO during the transition and through the filing of the fiscal year 2026 10-K.
Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 30 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Corporate Board Director Changes SEC Filings
August 31, 2026
US Corporate Board Director Changes SEC Filings — August 31, 2026
August 27, 2026
US Corporate Board Director Changes SEC Filings — August 27, 2026
August 26, 2026
US Corporate Board Director Changes SEC Filings — August 26, 2026
August 25, 2026
US Corporate Board Director Changes SEC Filings — August 25, 2026
🇺🇸 More from United States
View all →September 04, 2026
US Pre-Market SEC Filings Roundup — September 04, 2026
US Pre-Market SEC Filings Roundup
September 04, 2026
USA Corporate Events Calendar — September 04, 2026
USA Corporate Events Calendar
September 04, 2026
US Merger & Acquisition SEC Filings — September 04, 2026
US Merger & Acquisition SEC Filings
September 03, 2026
US Pre-Market SEC Filings Roundup — September 03, 2026
US Pre-Market SEC Filings Roundup